Does sildenafil (Viagra) improve premature ejaculation in men?

Sildenafil Alone Is Not Recommended as First-Line Treatment for Premature Ejaculation

Sildenafil (Viagra) should not be used as monotherapy for premature ejaculation in men without erectile dysfunction. The evidence shows that while sildenafil may improve sexual confidence and satisfaction, it does not significantly increase intravaginal ejaculatory latency time (IELT) when used alone 1.

Primary Treatment Recommendations

First-Line Pharmacotherapy

The AUA guideline clearly states that premature ejaculation can be treated effectively with several serotonin reuptake inhibitors (SRIs) or topical anesthetics 1. These are the recommended first-line options:

Oral SRIs (preferred first-line):

• Paroxetine: 10-40 mg daily or 20 mg 3-4 hours before intercourse 1
• Sertraline: 25-200 mg daily or 50 mg 4-8 hours before intercourse 1
• Fluoxetine: 5-20 mg daily 1
• Clomipramine: 25-50 mg daily or 25 mg 4-24 hours before intercourse 1

Topical anesthetics:

• Lidocaine/prilocaine cream (EMLA): 2.5% applied 20-30 minutes before intercourse 1
• Lidocaine/prilocaine spray: EMA-approved formulation increases IELT up to 6.3-fold 1

When Sildenafil May Have a Role

Sildenafil should only be considered in specific clinical scenarios:

1. Men with concomitant erectile dysfunction: If PE and ED coexist, treat the ED first or concomitantly 1. The AUA guideline explicitly states that PE may improve when concomitant ED is effectively treated 1.

2. Combination therapy: Sildenafil combined with paroxetine on a situational basis enhanced efficacy over paroxetine alone in one study of 80 men, though this increased side effects (headache and flushing) 1. The combination of sildenafil 50 mg with tramadol 100 mg showed superior results to either agent alone 2.

3. Adjunctive therapy: The hypothesis underlying sildenafil use is that pharmacologic maintenance of a rigid erection reduces the patient's need to rush to orgasm 1.

Evidence Against Sildenafil Monotherapy

Multiple studies demonstrate limited efficacy of sildenafil alone:

• A placebo-controlled study showed that while sildenafil increased ejaculatory control, confidence, and satisfaction scores, the change in IELT (1.6 vs. 0.6 minutes) did not reach statistical significance compared to placebo 3.

• A comparative study found no significant difference between sildenafil-only and placebo (55% vs. 40% effectiveness), while topical EMLA cream showed 77.3% effectiveness 4.

• A laboratory study found that while vardenafil significantly prolonged ejaculatory latency time compared to placebo, sildenafil did not 5.

However, more recent evidence suggests potential benefit:

• A 2007 study found sildenafil significantly more effective than both paroxetine and squeeze technique, with only 1.7% withdrawal rate versus 18.3% and 36.7% respectively 6.

• A 2013 randomized trial showed sildenafil improved sexual satisfaction significantly better than paroxetine and local anesthetics, though tramadol was superior for IELT prolongation 7.

Clinical Algorithm

Step 1: Confirm PE diagnosis through detailed sexual history (frequency, duration, degree of control, partner impact) 1.

Step 2: Assess for concomitant ED. If present, treat ED first with sildenafil or other PDE5 inhibitors 1.

Step 3: If PE persists or no ED exists, initiate first-line therapy:

• Start with lowest effective SRI dose (e.g., paroxetine 10 mg daily or 20 mg on-demand) 1
• Alternative: Topical lidocaine/prilocaine 20-30 minutes before intercourse 1

Step 4: If inadequate response to SRI monotherapy after 4-6 weeks, consider:

• Adding sildenafil 50 mg on-demand to existing SRI therapy 1
• Switching to tramadol 100 mg on-demand (superior IELT prolongation but addiction potential) 7

Step 5: For refractory cases, combination therapy with sildenafil plus tramadol may be considered 2.

Important Caveats

None of these pharmacologic therapies are FDA-approved for PE 1. All use is off-label, and this should be discussed with patients 1.

Sildenafil side effects include headache (15%), flushing (15%), dyspepsia (5%), abnormal vision (5%), and rhinitis (5%) 3. When combined with SRIs, side effect frequency increases 1.

Contraindications: Sildenafil must never be used with nitrates due to potentially life-threatening hypotension 8. Caution is required in patients with cardiovascular disease, recent MI/stroke, hypotension, or retinitis pigmentosa 8.

The 2025 EAU guideline recommends dapoxetine (a short-acting SSRI specifically approved for PE in many countries) and lidocaine/prilocaine spray as approved on-demand treatments, with off-label options including daily SSRIs or on-demand tramadol 1. PDE5 inhibitors alone do not significantly improve IELT but may enhance confidence and satisfaction 1.